608
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Unique challenges faced by the clinical evaluation of dengue vaccines

Pages 133-136 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sai Kit Lam. (2013) Challenges in reducing dengue burden; diagnostics, control measures and vaccines. Expert Review of Vaccines 12:9, pages 995-1010.
Read now
Monika Simmons, Nimfa Teneza-Mora & Robert Putnak. (2012) Advances in the development of vaccines for dengue fever. Vaccine: Development and Therapy 2, pages 1-14.
Read now

Articles from other publishers (10)

Rahul Shukla, Viswanathan Ramasamy, Rajgokul K. Shanmugam, Richa Ahuja & Navin Khanna. (2020) Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Rahul Shukla, Ravi K. Rajpoot, Upasana Arora, Ankur Poddar, Sathyamangalam Swaminathan & Navin Khanna. (2018) Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo. Frontiers in Microbiology 8.
Crossref
Ankur Poddar, Viswanathan Ramasamy, Rahul Shukla, Ravi Kant Rajpoot, Upasana Arora, Swatantra K. Jain, Sathyamangalam Swaminathan & Navin Khanna. (2016) Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies. BMC Biotechnology 16:1.
Crossref
Monika Simmons, Peifang Sun & Robert Putnak. (2016) Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine. PLOS ONE 11:4, pages e0152811.
Crossref
Melissa Hamm, Feng Wang & Richard R. Rustandi. (2015) Development of a capillary zone electrophoresis method for dose determination in a tetravalent dengue vaccine candidate. ELECTROPHORESIS 36:21-22, pages 2687-2694.
Crossref
Lav Tripathi, Shailendra Mani, Rajendra Raut, Ankur Poddar, Poornima Tyagi, Upasana Arora, Aravinda de Silva, Sathyamangalam Swaminathan & Navin Khanna. (2015) Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies. Frontiers in Microbiology 6.
Crossref
Lakshmy RamakrishnanMadhavan Radhakrishna PillaiRadhakrishnan R. Nair. (2015) Dengue Vaccine Development: Strategies and Challenges. Viral Immunology 28:2, pages 76-84.
Crossref
Shailendra Mani, Lav Tripathi, Rajendra Raut, Poornima Tyagi, Upasana Arora, Tarani Barman, Ruchi Sood, Alka Galav, Wahala Wahala, Aravinda de Silva, Sathyamangalam Swaminathan & Navin Khanna. (2013) Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies. PLoS ONE 8:5, pages e64595.
Crossref
Kulkanya Chokephaibulkit & Guey Chuen Perng. (2013) Challenges for the formulation of a universal vaccine against dengue. Experimental Biology and Medicine 238:5, pages 566-578.
Crossref
Guey Chuen Perng, Huan-Yao Lei, Yee-Shin Lin & Kulkanya Chokephaibulkit. (2011) Dengue Vaccines: Challenge and Confrontation. World Journal of Vaccines 01:04, pages 109-130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.